AEROVATE THERAPEUTICS, INC. |
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 20.29 USD | -2.22% |
|
-6.71% | -10.34% |
| 04-12 | Aerovate Therapeutics Insider Sold Shares Worth $334,478, According to a Recent SEC Filing | MT |
| 04-04 | Aerovate Therapeutics Insider Sold Shares Worth $300,033, According to a Recent SEC Filing | MT |
Chart calendar Aerovate Therapeutics, Inc.
d45d60eb70a8af.DVupsxhHPwzG7voHfhivd1pShmBPHDxWx5rPq1VPFs0.XTPm2yAEfWWWqaI_H03qPTtr9C46THA-pfu-khdifIBVM-vlc3RaeKO8nQ~9a13714caced3035fe28d770fef813fe
Upcoming events on Aerovate Therapeutics, Inc.
Past events on Aerovate Therapeutics, Inc.
| 25/03/2024 20:10 | Q4 2023 Earnings Release |
| 12/03/2024 | Jefferies Biotech on the Bay Miami Summit |
| 04/03/2024 | TD Cowen Health Care Conference |
| 06/02/2024 | Guggenheim Healthcare Biotechnology Conference |
| 13/11/2023 13:00 | Q3 2023 Earnings Release |
| 14/08/2023 13:00 | Q2 2023 Earnings Release |
| 07/06/2023 13:00 | Jefferies Global Healthcare Conference |
| 06/06/2023 14:00 | Annual General Meeting |
| 22/05/2023 16:30 | American Thoracic Society International Conference - Poster No: P220 |
| 15/05/2023 21:05 | Q1 2023 Earnings Release |
| 29/03/2023 21:50 | Q4 2022 Earnings Release |
| 08/03/2023 15:30 | Cowen Health Care Conference |
| 14/11/2022 12:45 | Q3 2022 Earnings Release |
| 15/08/2022 12:50 | Interim 2022 Earnings Release |
| 10/08/2022 20:30 | Wedbush PacGrow Healthcare Conference |
| 07/08/2022 | BTIG Biotechnology Conference |
| 21/06/2022 14:00 | Annual General Meeting |
| 09/06/2022 20:30 | Jefferies Healthcare Conference |
| 16/05/2022 22:15 | American Thoracic Society International Conference - Session B106 Poster No. 610 |
| 16/05/2022 13:00 | Q1 2022 Earnings Release |
Annual results
| Fiscal Period | December | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 |
|
EBITDA Million USD | Released Forecast Spread | 0,00 | 0,00 0,00 - | -53,2 -57,0 6.72% | 0,00 0,00 - | 0,00 |
|
EBIT Million USD | Released Forecast Spread | 0,00 | -23,0 -22,2 -3.52% | -53,2 -52,6 -1.18% | -81,4 -79,8 -1.99% | -92,5 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | 0,00 | -23,0 -22,5 -1.84% | -51,5 -51,9 0.7% | -75,5 -75,0 -0.58% | -88,3 |
|
Net income Million USD | Released Forecast Spread | -9,61 | -23,0 -22,2 -3.52% | -51,5 -51,7 0.3% | -75,5 -73,7 -2.46% | -89,0 |
|
EPS USD | Released Forecast Spread | -40,3 | -1,87 -1,58 -18.54% | -2,10 -2,10 -0.16% | -2,87 -2,84 -1.12% | -3,02 |
| Announcement Date | 06/05/21 | 30/03/22 | 29/03/23 | 25/03/24 | - |
Quarterly results
| Fiscal Period | December | 2021 Q4 | 2022 Q1 | 2022 Q2 | 2022 Q3 | 2022 Q4 | 2023 Q1 | 2023 Q2 | 2023 Q3 | 2023 Q4 | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 0,00 - | 0,00 | 0,00 | 0,00 | 0,00 | 0,00 |
|
EBIT Million USD | Released Forecast Spread | -8,27 -7,49 -10.41% | -11,0 -8,58 -28.38% | -12,2 -11,2 -9.23% | -14,2 -12,4 -14.41% | -15,9 -15,4 -2.76% | -17,6 -15,0 -17.31% | -20,3 -17,7 -14.64% | -21,4 -20,2 -5.78% | -22,1 -21,2 -4.13% | -22,2 | -22,7 | -23,3 | -23,9 | -26,1 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -8,22 -7,82 -5.15% | -10,9 -8,82 -23.73% | -12,0 -11,1 -7.67% | -13,6 -12,2 -11.2% | -15,0 -15,4 2.52% | -16,5 -14,6 -13.53% | -19,0 -17,2 -10.63% | -19,6 -19,3 -1.2% | -20,4 -19,9 -2.11% | -21,1 | -21,7 | -22,3 | -22,9 | -24,3 |
|
Net income Million USD | Released Forecast Spread | -8,22 -7,44 -10.55% | -10,9 -8,51 -28.18% | -12,0 -11,1 -7.76% | -13,6 -12,2 -11.02% | -15,0 -15,2 1.09% | -16,5 -14,8 -11.27% | -19,0 -17,3 -9.73% | -19,6 -19,6 0.11% | -20,4 -20,1 -1.69% | -21,4 | -21,9 | -22,5 | -23,1 | -24,3 |
|
EPS USD | Released Forecast Spread | -0,07 -0,31 77.24% | -0,45 -0,28 -59.57% | -0,49 -0,46 -7.69% | -0,56 -0,50 -12.56% | -0,61 -0,62 1.29% | -0,67 -0,60 -11.67% | -0,76 -0,70 -9.2% | -0,71 -0,69 -2.6% | -0,74 -0,71 -4.47% | -0,77 | -0,75 | -0,75 | -0,76 | -0,68 |
| Announcement Date | 30/03/22 | 16/05/22 | 15/08/22 | 14/11/22 | 29/03/23 | 15/05/23 | 14/08/23 | 13/11/23 | 25/03/24 | - | - | - | - | - |
More events
Past sector events for Aerovate Therapeutics, Inc.
| 02/05/2024 21:10 | DYNE THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | VIR BIOTECHNOLOGY, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:05 | RELAY THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 21:01 | GALAPAGOS NV: Q1 2024 Earnings Release |
| 02/05/2024 13:00 | ALNYLAM PHARMACEUTICALS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:05 | SHATTUCK LABS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | BLUEPRINT MEDICINES CORPORATION: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | KYMERA THERAPEUTICS, INC.: Q1 2024 Earnings Release |
| 02/05/2024 12:00 | IQVIA HOLDINGS INC.: Q1 2024 Earnings Release |
| 02/05/2024 11:30 | MODERNA, INC.: Q1 2024 Earnings Release |
Net sales - Quarter - Rate of surprise
Quarterly earnings - Rate of surprise
Net sales - Annual - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- AVTE Stock
- Calendar Aerovate Therapeutics, Inc.
